- President Biden will announce new tax credits for small and medium-sized business that provide paid time off for employees to get COVID-19 vaccines.
- Some states have more vaccine supply than demand.
- CVS will begin selling three over-the-counter COVID-19 tests that can be performed at home.
- New research shows a lower risk of COVID-19 transmission through surfaces compared to airborne transmissions.
- Some people with long-term COVID-19 effects say receiving the vaccine eased their symptoms.
Congress
- The Senate passed anti-Asian hate crime legislation. Hate crimes against Asians have increased during the pandemic.
Centers for Disease Control and Prevention (CDC) Updates
- The CDC published the following reports and websites updates:
- Overall U.S. COVID-19 Vaccine Distribution and Administration Update as of Thu, 22 Apr 2021 06:00:00 EST
- Cases in the U.S.
- CDC’s COVID-19 Weekly Partner Calls
- Reporting COVID-19 Vaccination Demographic Data
- Reporting COVID-19 Vaccinations in the United States
- Workplaces and Businesses
- Social Media Toolkit
- COVID-19 Vaccines are Important
- About COVID-19 Vaccines
- What You Need to Know About COVID-19 Vaccines
- COVID-19 Vaccines May Make You Feel Sick
- What You Should Know About the Possibility of COVID-19 Illness After Vaccination
- SARS-CoV-2 Variants
- Recommendation to Pause Use of Johnson & Johnson’s Janssen COVID-19 Vaccine
- Know Your Travel Risk
- Personal and Social Activities
- People at Increased Risk
Economy, Vaccines, Testing and Treatment
- Some states have more vaccine supply than demand.
- The Food and Drug Administration (FDA) ordered the facility that produced the faulty Johnson & Johnson (J&J) vaccine doses to temporarily stop producing vaccines until its inspection of the facility is complete.
- CVS will begin selling three over-the-counter COVID-19 tests that can be performed at home.
- New research shows a lower risk of COVID-19 transmission through surfaces compared to airborne transmissions.
- New clinical trial data shows J&J’s vaccine is effective against certain COVID-19 variants.
- The CDC Advisory Committee on Immunization Practices (ACIP) is meeting on Friday to continue its discussion of the safety risk associated with the J&J vaccine. ACIP could issue new recommendations for warnings or treatment guidelines which could pave the way for resuming J&J vaccinations.
- J&J will resume distributing its vaccine in Europe.
- The CDC is investigating a “handful” of possible new cases of blood clots associated with the J&J vaccine.
- Some people with long-term COVID-19 effects say receiving the vaccine eased their symptoms.
